Mersana Therapeutics Inc (NASDAQ: MRSN) on Monday, plunged -3.72% from the previous trading day, before settling in for the closing price of $2.15. Within the past 52 weeks, MRSN’s price has moved between $1.22 and $6.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 12371.94% over the last five years. The company achieved an average annual earnings per share of 60.21%. With a float of $86.56 million, this company’s outstanding shares have now reached $122.87 million.
The firm has a total of 123 workers. Let’s measure their productivity. In terms of profitability, gross margin is 48.0%, operating margin of -228.07%, and the pretax margin is -212.99%.
Mersana Therapeutics Inc (MRSN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mersana Therapeutics Inc is 29.93%, while institutional ownership is 66.09%. The most recent insider transaction that took place on Oct 28 ’24, was worth 3,580. In this transaction SVP, Chief Development Officer of this company sold 1,884 shares at a rate of $1.90, taking the stock ownership to the 54,731 shares. Before that another transaction happened on Oct 28 ’24, when Company’s Officer proposed sale 1,884 for $2.04, making the entire transaction worth $3,843.
Mersana Therapeutics Inc (MRSN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 60.21% per share during the next fiscal year.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
Mersana Therapeutics Inc (MRSN) is currently performing well based on its current performance indicators. A quick ratio of 2.35 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Analysing the last 5-days average volume posted by the [Mersana Therapeutics Inc, MRSN], we can find that recorded value of 1.14 million was lower than the volume posted last year of 1.57 million. As of the previous 9 days, the stock’s Stochastic %D was 12.52%. Additionally, its Average True Range was 0.26.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 52.80%, which indicates a significant increase from 16.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.77% in the past 14 days, which was lower than the 105.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.17, while its 200-day Moving Average is $2.55. Now, the first resistance to watch is $2.20. This is followed by the second major resistance level at $2.34. The third major resistance level sits at $2.43. If the price goes on to break the first support level at $1.97, it is likely to go to the next support level at $1.88. Should the price break the second support level, the third support level stands at $1.74.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
Market capitalization of the company is 239.04 million based on 123,533K outstanding shares. Right now, sales total 36,860 K and income totals -171,670 K. The company made 12,600 K in profit during its latest quarter, and -11,500 K in sales during its previous quarter.
